Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice

Molecular Carcinogenesis

Volumn 15, Issue 1, 1996, Pages 44-56

  Kenney, Nicholas J ^a   Smith, Gilbert H ^b   Maroulakou, Ioanna G ^c   Green, Jeff H ^c   Muller, William J ^d   Callahan, Robert ^b   Salomon, David S ^b   Dickson, Robert B ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Amphiregulin; Cripto 1; Growth factors; Mammary cancer; Transgenic mouse

Indexed keywords

AMPHIREGULIN; CRIPTO; EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; BLOTTING, WESTERN; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0030003583     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199601)15:1<44::AID-MC7>3.0.CO;2-S     Document Type: Article

References (37)

1. Dickson RB, Gottardis M, Merlino G. Molecular insights into breast cancer from transgenic mouse models Bioassays 13 591-596, 1991.
2. Cardiff RD, Sinn E, Muller WJ, Leder P Transgenic oncogene mice. Am J Pathol 139:495-501, 1991.
3. Muller WJ, Lee FS, Dickson G, Peters P, Pattengale PK, Leder P. The int-2 gene product acts as an epithelium growth factor in transgenic mice EMBO J 7:907-913, 1990
4. Mortison BW, Leder P Neu and ras initiate murine mammary tumors that share genetic markers generally absent in myc and int-2 initiated tumors. Oncogene 9:3417-3426, 1994.
5. Maroulakou G, Anver M, Garrett L, Green JE Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3 (1) SV 40 TAG fusion gene Proc Natl Acad Sci USA 91:11236-11240, 1994.
6. Guy CT, Cardiff RD, Muller WJ Induction of mammary tumors by expression of polyomavirus middle t oncogens. A transgenic mouse model for metastatic disease Mol Cell Biol 12:954-961, 1992
7. Jhappan C, Gallahan D, Stahle C, et al Expression of an activated notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary salivary glands. Genes Dev 6 345-355, 1992
8. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146, 1990.
9. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene Cell 54:105-115, 1988.
10. Plowman GD, Green JM, McDonald UL. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibiting activity. Mol Cell Biol 10:1969-1981, 1990.
11. Shoyab M, McDonald UL, Bradley JG, Todaro GJ Amphiregulin. A bi-functional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7 Proc Natl Acad Sci USA 85:6528-6532, 1989.
12. Shoyab M, Plowman GD, McDonald UL, Bradley JG, Todaro GJ. Structure and function of human amphiregulin: A member of the epidermal growth factor family Science 243:1074-1076, 1989.
13. erbB2. J Biol Chem 268:2924-2931, 1993.
14. Johnson GR, Wong L. Heparin sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J Biol Chem 269 27149-27154, 1994.
15. Thorne BA, Plowman GD The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion Mol Cell Biol 14 1635-1646, 1994.
16. Kenney N, Johnson G, Selwin MP, et al. Transforming growth factor (TGFα) and amphiregulin (AR) as autocrine growth factors in non-transformed, immortalized 184A1N4 human mammary epithelial cells Molecular and Cellular Differentiation 1:163-184, 1993.
17. Li S, Plowman GD, Buckley SD, Shipley GD Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J Cell Physiol 153:103-111, 1992.
18. Normanno N, Selvan MP, Saeki T, et al. Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erbB-2 transformed human mammary epithelial cells Proc Natl Acad Sci USA 91:2790-2794, 1994.
19. Kenney NJ, Huang R-P, Johnson G, et al. Detection and location of amphiregulin and cripto-1 in the developing mouse mammary gland Mol Reprod Dev 4:277-286, 1995.
20. LeJeune S, Leck R, Horak E, Plowman G, Greenall M, Harris A Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer Cancer Res 53 3597-3602, 1993.
21. Normanno N, Qi C-F, Gullick W, et al. Expression of amphiregulin, cripto-1, and heregulin α in human breast cancer cells Int J Oncol 2:903-911, 1993
22. Qi C-F, Liscia DS, Normanno N, et al. Expression of transforming growth factor α, amphiregulin, and cripto-1 in human breast carcinomas Br J Cancer 69:903-910, 1994.
23. Martinez-Lacaci IM, Saceda M, Plowman G, et al Regulation of amphiregulin gene expression by 12-O-tetradecanoylphorbol-13-acetate and 17-β-estradiol in human breast cancer cell lines. Endocrinology 136 3983-3992, 1995
24. Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG Molecular characterization of a gene of the EGF family expressed in undifferentiated human NTERA2 teratocarcinoma cells EMBO J 8 1987-1991, 1989
25. Dono R, Scalera L, Pacifico F, Acampora D, Persico MG, Simeone A. The murine cripto gene Expression during mesoderm induction and early heart morphogenesis Development 118 1157-1168, 1993
26. Brandt R, Normanno N, Gullick WJ, et al. Identification and biological characterization of an epidermal growth factor-related protein Cripto-1 J Biol Chem 269:17320-17328, 1994
27. Ciardiello F, Dono R, Kim N, Persico MG, Salomon DS. Overexpression of cripto, a novel gene of the epidermal growth factor family, leads to in vitro transformation of a normal mouse mammary epithelial cell line Cancer Res 51:1051-1054, 1991.
28. Schlessinger J, Ullrich A Growth-factor signalling by receptor tyrosine kinases Neuron 9:383-391, 1992.
29. Carraway KL, Cantley LC. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth factor signalling. Cell 78:5-8, 1994.
30. Snedeker SM, Brown CF, DiAugustine RP. Expression and functional properties of transforming growth factor-α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA 88:276-280, 1991.
31. Brown CF, Teng CT, Pentecost BT, DiAugustine RP Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells Mol Endocrinol 3:1077-1083, 1989.
32. Johnson GR, Pringent SA, Gullick WJ, Stromberg K Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length J Biol Chem 268:18835-18843, 1993.
33. Baserga R. Oncogenes and the strategy of growth factors Cell 79:927-930, 1994.
34. Piepkorn M, Lo C, Plowman G. Amphiregulin-independent proliferation of cultured human keratinocytes: Autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycoaminoglycans. J Cell Physiol 159:114-120, 1994
35. Kimura H. Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity Proc Natl Acad Sci USA 90:2165-2169, 1993.
36. Ebert M, Yokoyoma M, Korbon MS, et al. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 54:3959-3962, 1994.
37. Su Z, Austin UN, Zimmer SG, Fisher PB. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 8:1211-1219, 1993.